HAS Should Not Be NICE: Rejecting Imaginary Worlds in the French Technology Assessment Guidelines
Pricing decisions and access to pharmaceuticals should be evidence based. Unfortunately, the French guidelines for technology assessment, in their adoption of the National Institute for Health and Clinical Excellence (NICE) reference case modeling standard ensure that this is not the case. Rather th...
Saved in:
Main Author: | Paul C Langley (Author) |
---|---|
Format: | Book |
Published: |
University of Minnesota Libraries Publishing,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Imaginary Worlds and Efficiency Frontiers: Should We Abandon the IQWiG Health Technology Assessment Model?
by: Paul C Langley
Published: (2017) -
True North: Building Imaginary Worlds with the Revised Canadian (CADTH) Guidelines for Health Technology Assessment
by: Paul C Langley
Published: (2017) -
Information or Evidence? Abandoning Imaginary Worlds for Blockchains in Health Technology Assessment
by: Paul Langley
Published: (2018) -
The National Pharmaceutical Council: Endorsing the Construction of Imaginary Worlds in Health Technology Assessment
by: Paul C Langley
Published: (2020) -
Transparency, Imaginary Worlds and ICER Value Assessments
by: Paul C. Langley
Published: (2017)